VM
GBT

VHCP Management’s Global Blood Therapeutics, Inc. GBT Stock Holding History

VHCP Management’s Portfolio GBT Stock Details GBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-72,990
Closed -$1.21M – 25
2016
Q2 		$1.21M Hold
72,990
– – 1.26% 17
2016
Q1 		$1.16M Buy
72,990
+12,299
+20% +$219K 1.01% 19
2015
Q4 		$1.96M Buy
+60,691
New +$2.63M 1.19% 14

Other funds holding GBT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $143M AUM 102.52% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
FCMI
Foresite Capital Management III Larkspur, California $37.9M AUM 6.87% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return

VHCP Management's GBT Position: Q3 2016 in Review

VHCP Management sold out of Global Blood Therapeutics, Inc. (GBT) in Q3 2016, closing a stake of 72,990 shares — an estimated $1.21M sold.

VHCP Management first reported a position in GBT in Q4 2015 and held it in 3 quarters. The position peaked at $1.96M in Q4 2015. 84 funds tracked by Wall St. Rank hold GBT as of Q3 2016.

  • VHCP Management reported no remaining Global Blood Therapeutics, Inc. position as of Q3 2016 after selling out during the quarter.
  • VHCP Management sold 72,990 Global Blood Therapeutics, Inc. shares in Q3 2016, an estimated $1.21M.
  • VHCP Management first reported a position in Global Blood Therapeutics, Inc. in Q4 2015 and held it in 3 quarters.
  • VHCP Management's Global Blood Therapeutics, Inc. position peaked at $1.96M in Q4 2015.
  • 84 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q3 2016.

Based on VHCP Management's 13F filing for Q3 2016, filed 14 Nov 2016.